Community-acquired pneumonia conveys a high human and financial burden. Few therapeutic progresses have been made since the introduction of penicillin. Improving the prognosis by controlling the host inflammatory response is a biologically sound strategy, which has proved its efficacy in some respiratory and infectious diseases. Adjunction of corticosteroids to antibiotic treatment has been tested in a few controlled studies. However, results are not indicative of any clinical benefit.

We present a critical review of the available literature.

Rev Med Suisse. 2010 Oct 20;6(267):1977-8, 1980-1
Authors: Fleury G, Garin N
Related Articles
Read Full Article